Zosano grants Asahi exclusive rights in China, Japan, Korea, and Taiwan to Zosano's ZP patch technology to develop a transdermal patch formulation of Teribone teriparatide to treat osteoporosis

Zosano Pharma Corp.

U.S. / Private Biopharma

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Asahi Kasei Pharma Corp.

Japan / Private Biopharma

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Terminated

Sample

01/01/2009

announced

01/01/2009

Terminated